Argos Therapeutics (FRA:77AA) Total Liabilities : €20.10 Mil (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Total Liabilities?

Argos Therapeutics's Total Liabilities for the quarter that ended in Sep. 2018 was €20.10 Mil.

Argos Therapeutics's quarterly Total Liabilities increased from Mar. 2018 (€20.55 Mil) to Jun. 2018 (€21.34 Mil) but then declined from Jun. 2018 (€21.34 Mil) to Sep. 2018 (€20.10 Mil).

Argos Therapeutics's annual Total Liabilities increased from Dec. 2015 (€54.38 Mil) to Dec. 2016 (€86.30 Mil) but then declined from Dec. 2016 (€86.30 Mil) to Dec. 2017 (€25.36 Mil).

Argos Therapeutics Total Liabilities Historical Data

The historical data trend for Argos Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Total Liabilities Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Total Liabilities

Get a 7-Day Free Trial

92.64

26.78

54.38

86.30

25.36

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Total Liabilities	Get a 7-Day Free Trial															35.83	25.36	20.55	21.34	20.10

Argos Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Argos Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2017 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.076	+	(10.253	+	0.141
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	6.89	+	0)
	=	25.36

Total Liabilities	=	Total Assets (A: Dec. 2017 )	-	Total Equity (A: Dec. 2017 )
	=	17.557	-	-7.803
	=	25.36

Argos Therapeutics's Total Liabilities for the quarter that ended in Sep. 2018 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.03	+	(10.252	+	1.3322676295502E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	1.818	+	0)
	=	20.10

Total Liabilities	=	Total Assets (Q: Sep. 2018 )	-	Total Equity (Q: Sep. 2018 )
	=	9.325	-	-10.775
	=	20.10

Argos Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines